The Journal of

1.     Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 US Preventive Services Task Force RecommendationEffectiveness of Breast Cancer Screening. Ann Intern Med. 2016;164(4):244–55.
2.     KAZEMI A, ESKANDARI O, AMIN MM, NESAEE P. A SURVEY ON BREAST CANCER STATUS IN KURDISTAN PROVINCE ON MEDICAL GEOGRAPHY VIEWPOINT DURING 2006–2010. 2015;[Persian]
3.     Golmohammadi R, Pejhan A. Gene experison of cell proliferative marker Ki67 in breast cancer. J Gorgan Univ Med Sci. 2011;13(3):65–71. [Persian]
4.     Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Pourhoseingholi A, Barzegar F, et al. Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev. 2012;13(1):367–70. [Persian]
5.     Vahdaninia M, HARIR CA, Montazeri A. Five-year survival in Iranian breast cancer patients: A prospective study. 2003; [Persian]
6.     Kleinbaum DG, Klein M. Survival analysis. Vol. 3. Springer; 2010.
7.     Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, Safaee A, Abadi A, Zali MR. Comparing Cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev. 2007;8(3):412.
8.     Ibrahim JG, Chen M-H, Sinha D. Bayesian survival analysis. Wiley Online Library; 2005.
9.     Cureton EE, D’Agostino RB. Factor analysis: An applied approach. Psychology press; 2013.
10.     Therneau TM, Grambsch PM. Extending the Cox model. Ed P Bickel P Diggle Fienberg K Krickeberg. 2000;51.
11.     Dardis C. survMisc: AN R PACKAGE TO FACILITATE SURVIVAL ANALYSIS. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA; 2013. p. 32–32.
12.     Zhou H, Hanson T. spBayesSurv: Bayesian Modeling and Analysis of Spatially Correlated Survival Data. R Package Version. 2014;1(3).
13.     Plummer M, Best N, Cowles K, Vines K. CODA: convergence diagnosis and output analysis for MCMC. R News. 2006;6(1):7–11.
14.     Tazhibi M, Fayaz M, Mokarian F. Detection of prognostic factors in metastatic breast cancer. J Res Med Sci Off J Isfahan Univ Med Sci. 2013;18(4):283. [Persian]  
15.     Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11(2):174–83.
16.     Moslemi D, GHOLIZADEH PA, Hajian K, Sum SH, Pourghasem M, Jahantigh R. Comparison of Modified Radical Mastectomy with Breast Conservative Therapy and Radiotherapy in Patients with Breast Cancer. 2012; [Persian]
17.     Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients. bmj. 2015;351:h4901.
18.     Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer. 2007;109(1):25–32.
19.     Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, et al. Crossover Effects of Estrogen Receptor Status on Breast Cancer-Specific Hazard Rates by Age and Race. PloS One. 2014;9(10):e110281.
20.     Vostakolaei FA, Broeders MJ, Rostami N, Van Dijck JA, Feuth T, Kiemeney LA, et al. Age at diagnosis and breast cancer survival in iran. Int J Breast Cancer. 2012;2012.
21.     Fallahzadeh H, Momayyezi M, Akhundzardeini R, Zarezardeini S. Five year survival of women with breast cancer in Yazd. Asian Pac J Cancer Prev. 2014;15(16):6597–601.
22.     Haghighat S. Survival rate and its correlated factors in breast cancer patients referred to Breast Cancer Research Center. Iran J Breast Dis. 2013;6(3):28–36. [Persian]  
23.     Ibrahim JG, Chen M-H, Sinha D. Criterion-based methods for Bayesian model assessment. Stat Sin. 2001;419–43.